Marcia L. Stefanick, Ph.D.

Administrative Appointments

• Professor of Medicine (Research), Stanford University (2003 - present)
• Associate Professor of Medicine (Research), Stanford University (1997 - 2003)

Honors and Awards

• Fellow, American Heart Association (2001-present)
• Member, Stanford University School of Medicine Committee on Admissions (October 1999-present)
• Member, Phi Delta Kappa (International German Honor Society) (19-- to present)
• Member, Sigma Xi (Scientific Research Society) (19--to present)
• Fellow, American Heart Association Council of Arteriosclerosis, Thrombosis and Vascular Biology (1989-present)

Professional Education

Graduate & Fellowship Program Affiliations

• Health Research and Policy
• Medicine
• Obstetrics and Gynecology

Internet Links

• https://prevention.stanford.edu/

Current Research Interests

Dr Stefanick is Principal Investigator of Stanford's (1) Women's Health Initiative (WHI) Center which is now following ~3900 women (12% minority), now 60-90 years of age, who have participated in the WHI diet, hormone, or calcium/vitamin trials (focused on heart disease, breast and colorectal cancer and osteoporotic bone fractures) or a study of natural aging since 1995, (2) NCI Women's Healthy Eating and Living (WHEL) trial, which is following 500 of the total 3000 breast cancer survivors enrolled in this NCI trial to determine whether a plant-based diet can prevent breast cancer recurrence; and (3) MrOs, Study of Osteoporotic Fractures in Men (the MrOS study) which is following the health status of nearly 1000 of the 6000 men, aged 65 and over, in the NIAMS MrOS study, with particular interest in osteoporotic fractures and prostate cancer and the role of Sleep on cardiovascular health. Dr. Stefanick is actively involved in Women's Health @ Stanford (based in the Department of Obstetrics and Gynecology) and is currently developing a women's heart health program, HerHeart, for Stanford's Cardiovascular Institute. She is also Leader for the Cancer Prevention and Control Program of Stanford's Comprehensive Cancer Center and Program Director for Stanford's Building Interdisciplinary Research Careers in Women's Health (BIRCWH) mentorship program, funded by the NIH Office of Research on Women's Health.
Dr. Stefanick has been the investigator-elected Chair of the Women�s Health Initiative (WHI) Steering and Executive Committees from 1998 to 2005, at which time she was elected as Chair of the WHI Extension Study Executive Committee, which is overseeing the 5-year continuation of the project nationwide. She participates in a broad range of scientific activities for the NHLBI and American Heart Association. She has been invited to speak at many prominent national and international meetings in the area of chronic disease prevention and health promotion across the lifespan,...

Clinical Trials

• Sex Differences in Coronary Pathophysiology Recruiting

Publications

• Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J. JAMA. 2011; 305 (13): 1305-14
• Physical activity and survival in postmenopausal women with breast cancer: results from the women's health initiative. Irwin ML, McTiernan A, Manson JE, Thomson CA, Sternfeld B, Stefanick ML, Wactawski-Wende J, Craft L, Lane D, Martin LW, Chlebowski R. Cancer Prev Res (Phila). 2011; 4 (4): 522-9
• Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL. JAMA. 2010; 304 (15): 1684-92
• Breast cancer after use of estrogen plus progestin in postmenopausal women. Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G. N Engl J Med. 2009; 360 (6): 573-87
• Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW, Wactawski-Wende J, Gass M, Kotchen JM, Johnson KC, O'Sullivan MJ, Ockene JK, Chen C, Hubbell FA. Lancet. 2009; 374 (9697): 1243-51